UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047060
Receipt number R000053660
Scientific Title Effects of a research food on total body water
Date of disclosure of the study information 2022/09/10
Last modified on 2022/09/07 08:32:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of a research food on total body water

Acronym

Effects of a research food on total body water

Scientific Title

Effects of a research food on total body water

Scientific Title:Acronym

Effects of a research food on total body water

Region

Japan


Condition

Condition

N/A(healthy adults)

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to examine effects of a research food on total body water.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total body water

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single ingestion of the test food - single ingestion of the placebo food

Interventions/Control_2

Single ingestion of the placebo food - single ingestion of the test food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Men and women aged 20 to 65 years at the time of obtaining consent.
2)BMI of 18.5 kg/m^2or more but less than 25.0 kg/m^2.
3)Those who have received sufficient explanation of the test, understand the contents, and can give written consent in person.
4) Those who have completed two doses of the new coronavirus vaccine.

Key exclusion criteria

1)Those who have current medical treatments, or who are planning some kind of treatment the test period.
2)Those who constantly use medicines that may affect test results.(diuretic, antidiuretic, etc.).Those who take health foods and supplements (oral rehydration solution, saw palmettoetc.) daily, and those who may take or take them during the test period.
3)Those who are scheduled to take medication or receive vaccinations between one week before the first test date and the second test date.
4)Those who may onset seasonal allergies such as hay fever and take medicines during test period.
5)Those who may change their lifestyle (night shift, long trip, etc.) during test period.
6)Heavy drinkers of alcohol.
7)Those who have a history or current history of serious diseases of the heart, liver, kidneys, digestive organs, etc.
8)Individuals with probable seasonal allergy, such as pollinosis, during the test period.
9) Those who are pregnant, lactating, or intend to become pregnant during the study period.
10)Those with allergies to medicines or food.
11)Those who are currently participating in a clinical trial of another drug or health food, and plan to participate in another clinical trial within 4 weeks of the end of the trial, or after consenting to participate in the trial.
12)Patients who are judged to be inappropriate for participation in the study by the principal investigator or sub-investigator.

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Toshihiro
Middle name
Last name Kawama

Organization

Morinaga & Co., Ltd.

Division name

Health Science and Research Center, R&D institute

Zip code

230-8504

Address

2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama

TEL

045-571-6140

Email

t-kawama-jb@morinaga.co.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Morinaga

Organization

Morinaga & Co., Ltd.

Division name

Health Science and Research Center, R&D institute

Zip code

230-8504

Address

2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama, Kanagawa

TEL

045-571-6140

Homepage URL


Email

m-morinaga-bj@morinaga.co.jp


Sponsor or person

Institute

Morinaga & Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Morinaga & Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 01 Month 31 Day

Date of IRB

2022 Year 01 Month 31 Day

Anticipated trial start date

2022 Year 03 Month 17 Day

Last follow-up date

2022 Year 03 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 02 Day

Last modified on

2022 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053660


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name